These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15636051)

  • 1. Pregnancy-associated plasma protein A during hemodialysis with polyamide and diacetate cellulosic membranes.
    Kalousová M; Lachmanová J; Mokrejsová M; Míková B; Fialová L; Malbohan IM; Tesar V; Zimá T
    Int J Artif Organs; 2004 Nov; 27(11):943-8. PubMed ID: 15636051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous iron gluconate administration increases circulating PAPP-A in hemodialysis patients.
    Hodkova M; Kalousova M; Dusilova-Sulkova S; Malbohan IM; Zima T
    Ren Fail; 2005; 27(6):707-11. PubMed ID: 16350822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hemodiafiltration on pregnancy-associated plasma protein A (PAPP-A) and related parameters.
    Kalousová M; Hodková M; Dusilová-Sulková S; Uhrová J; Tesar V; Zima T
    Ren Fail; 2006; 28(8):715-21. PubMed ID: 17162432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of pregnancy-associated plasma protein-a to renal function and dialysis modalities.
    Fialová L; Kalousová M; Soukupová J; Sulková S; Merta M; Jelínková E; Horejsí M; Srámek P; Malbohan I; Mikulíková L; Tesar V; Zima T
    Kidney Blood Press Res; 2004; 27(2):88-95. PubMed ID: 14739577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy-Associated Plasma Protein A2 in Hemodialysis Patients: Significance for Prognosis.
    Kalousová M; Dusilová-Sulková S; Kuběna AA; Zakiyanov O; Levová K; Bocková M; Gedeonová E; Song XC; Ermini ML; Špringer T; Homola J; Tesař V; Zima T
    Kidney Blood Press Res; 2017; 42(3):509-518. PubMed ID: 28854436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epoetin requirement does not depend on dialysis dose when Kt/N > 1.33 in patients on regular dialysis treatment with cellulosic membranes and adequate iron stores.
    Movilli E; Cancarini GC; Vizzardi V; Camerini C; Brunori G; Cassamali S; Maiorca R
    J Nephrol; 2003; 16(4):546-51. PubMed ID: 14696757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased levels of pregnancy-associated plasma protein A are associated with mortality in hemodialysis patients: preliminary results.
    Kalousová M; Horejsí M; Fialová L; Soukupová J; Sulková S; Malbohan I; Tesar V; Zima T
    Blood Purif; 2004; 22(3):298-300. PubMed ID: 15166492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between hydroperoxides and malondialdehyde as markers of acute oxidative injury during hemodialysis.
    Lucchi L; Iannone A; Bergamini S; Stipo L; Perrone S; Uggeri S; Gatti V; Ferrari F; Tomasi A; Albertazzi A
    Artif Organs; 2005 Oct; 29(10):832-7. PubMed ID: 16185346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-free plasma DNA during Hemodialysis.
    Opatrna S; Wirth J; Korabecna M; Sefrna F
    Ren Fail; 2009; 31(6):475-80. PubMed ID: 19839825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.
    Afzali B; Bakri RS; Bharma-Ariza P; Lumb PJ; Dalton N; Turner NC; Wierzbicki AS; Crook MA; Goldsmith DJ
    J Nephrol; 2003; 16(4):540-5. PubMed ID: 14696756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dialysis filter type determines the acute effect of haemodialysis on endothelial function and oxidative stress.
    Kosch M; Levers A; Fobker M; Barenbrock M; Schaefer RM; Rahn KH; Hausberg M
    Nephrol Dial Transplant; 2003 Jul; 18(7):1370-5. PubMed ID: 12808175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of membrane permeability on inflammation and arterial stiffness: a randomized trial.
    Li PK; Cheng YL; Leung CB; Szeto CC; Chow KM; Kwan BC; Ng ES; Fok QW; Poon YL; Yu AW
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):652-8. PubMed ID: 20203165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the inflammatory and oxidative stress markers during a single hemodialysis session in patients with chronic kidney disease.
    Sangeetha Lakshmi B; Harini Devi N; Suchitra MM; Srinivasa Rao PVLN; Siva Kumar V
    Ren Fail; 2018 Nov; 40(1):534-540. PubMed ID: 30277113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy-associated plasma protein-A is an independent short-time predictor of mortality in patients on maintenance haemodialysis.
    Etter C; Straub Y; Hersberger M; Räz HR; Kistler T; Kiss D; Wüthrich RP; Gloor HJ; Aerne D; Wahl P; Klaghofer R; Ambühl PM
    Eur Heart J; 2010 Feb; 31(3):354-9. PubMed ID: 19850559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in and clearance of cell-free plasma DNA in hemodialysis quantified by real-time PCR.
    García Moreira V; de la Cera Martínez T; Gago González E; Prieto García B; Alvarez Menéndez FV
    Clin Chem Lab Med; 2006; 44(12):1410-5. PubMed ID: 17163815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of oxidative and antioxidative capacity during high-flux hemodialysis using two different membranes.
    Schönermarck U; Dengler C; Ebeling F; Heydenreich M; Hillebrand GF; Samtleben W
    Clin Nephrol; 2006 Nov; 66(5):357-63. PubMed ID: 17140165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy-associated plasma protein-A predicts survival in end-stage renal disease-confounding and modifying effects of cardiovascular disease, body composition and inflammation.
    Nilsson E; Cao Y; Lindholm B; Ohyama A; Carrero JJ; Qureshi AR; Stenvinkel P
    Nephrol Dial Transplant; 2018 Jun; 33(6):971-977. PubMed ID: 28992321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocompatibility and functional performance of a polyethylene glycol acid-grafted cellulosic membrane for hemodialysis.
    Sirolli V; Di Stante S; Stuard S; Di Liberato L; Amoroso L; Cappelli P; Bonomini M
    Int J Artif Organs; 2000 Jun; 23(6):356-64. PubMed ID: 10919752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of oral vitamin E therapy on micro-inflammation and cardiovascular disease markers in chronic hemodialysis patients.
    Hodkova M; Dusilova-Sulkova S; Kalousova M; Soukupova J; Zima T; Mikova D; Malbohan IM; Bartunkova J
    Ren Fail; 2006; 28(5):395-9. PubMed ID: 16825088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.